0001104659-23-082737.txt : 20230720 0001104659-23-082737.hdr.sgml : 20230720 20230720162023 ACCESSION NUMBER: 0001104659-23-082737 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230718 FILED AS OF DATE: 20230720 DATE AS OF CHANGE: 20230720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KPCB PANDEMIC & BIO DEFENSE FUND LLC CENTRAL INDEX KEY: 0001356809 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41742 FILM NUMBER: 231100082 BUSINESS ADDRESS: STREET 1: 2750 SAND HILL RD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-233-2750 MAIL ADDRESS: STREET 1: 2750 SAND HILL RD CITY: MENLO PARK STATE: CA ZIP: 94025 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KPCB PBD Associates, LLC CENTRAL INDEX KEY: 0001497523 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41742 FILM NUMBER: 231100083 BUSINESS ADDRESS: STREET 1: C/O KLEINER PERKINS CAUFIELD & BYERS STREET 2: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-233-2750 MAIL ADDRESS: STREET 1: C/O KLEINER PERKINS CAUFIELD & BYERS STREET 2: 2750 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sagimet Biosciences Inc. CENTRAL INDEX KEY: 0001400118 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205991472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 155 BOVET RD., SUITE 303 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: (650) 561-8600 MAIL ADDRESS: STREET 1: 155 BOVET RD., SUITE 303 CITY: SAN MATEO STATE: CA ZIP: 94402 FORMER COMPANY: FORMER CONFORMED NAME: 3-V Biosciences, Inc. DATE OF NAME CHANGE: 20070521 4 1 tm2321276-24_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-07-18 0 0001400118 Sagimet Biosciences Inc. SGMT 0001497523 KPCB PBD Associates, LLC C/O KLEINER PERKINS CAUFIELD & BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 0001356809 KPCB PANDEMIC & BIO DEFENSE FUND LLC C/O KLEINER PERKINS CAUFIELD & BYERS 2750 SAND HILL ROAD MENLO PARK CA 94025 0 0 1 0 0 Common Stock 2023-07-18 4 J 0 38763 D 0 I See footnote Series A Common Stock 2023-07-18 4 J 0 38763 A 38763 I See footnote Series A Common Stock 2023-07-18 4 C 0 1860712 A 1899475 I See footnote Series A Preferred Stock 2023-07-18 4 C 0 539006 0 D Common Stock 6781 0 I See footnote Series B Preferred Stock 2023-07-18 4 C 0 493370 0 D Common Stock 6208 0 I See footnote Series B-1 Preferred Stock 2023-07-18 4 C 0 8596590 0 D Common Stock 108163 0 I See footnote Series C Preferred Stock 2023-07-18 4 C 0 8596589 0 D Common Stock 108163 0 I See footnote Series D Preferred Stock 2023-07-18 4 C 0 6103580 0 D Common Stock 76796 0 I See footnote Series E Preferred Stock 2023-07-18 4 C 0 103127234 0 D Common Stock 1297549 0 I See footnote Series F Preferred Stock 2023-07-18 4 C 0 20430107 0 D Common Stock 257052 0 I See footnote Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was reclassified into one share of Series A Common Stock. Upon closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock (collectively, the "Preferred Stock") automatically converted into on a 79.4784-to-one basis into Series A Common Stock. The Preferred Stock had no expiration date. Represents shares held directly by KPCB Pandemic and Bio Defense Fund, LLC ("KPCB PBD"). The managing member of KPCB PBD is KPCB PBD Associates, LLC ("KPCB PBD Associates"). All securities are held for convenience in the name of "KPCB Holdings, Inc., as nominee". KPCB PBD Associates disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any of the reported shares for purposes of Section 16 or any other purpose. KPCB PBD Associates, LLC, By: /s/ Susan Biglieri, CFO 2023-07-20 KPCB Pandemic and Bio Defense Fund, LLC, By: KPCB PBD Associates, LLC, its managing member, By: /s/ Susan Biglieri, CFO 2023-07-20